Literature DB >> 29599844

Effect of the polyphenol composition BP-C3 on haematological and intestinal indicators of 5-fluorouracil toxicity in mice.

Andrey V Panchenko1, Elena I Fedoros1,2, Sergey E Pigarev2, Mikhail A Maydin1, Ekaterina A Gubareva1, Maria N Yurova1, Galina S Kireeva1, Galina P Lanskikh1, Margarita L Tyndyk1, Vladimir N Anisimov1.   

Abstract

BP-C3 is a formulation, which comprises lignin-derived polyphenolic composition of benzenepolycarboxylic acids (BP-Cx-1) with iron complex, selenium, ascorbic acid and retinol, and possesses geroprotective activity. The present study examined the effect of BP-C3 (80 mg/kg, administered 18 times in total by gavage) on the development of haematological and intestinal manifestations of toxicity following 5-fluorouracil (5-FU; 150 mg/kg, administered once via intravenous injection) administration in outbred male Swiss-H Rappolovo (SHR) mice. The use of BP-C3 on therapeutic and preventative/therapeutic schedules demonstrated that it was protective against the toxic effect of 5-FU exerted on the lymphopoietic organs. Administering ВР-С3 24 h after 5-FU (therapeutic schedule) had an effect on the recovery of leukopoiesis and prevented anaemia in the mice. In the mice that received 5-FU and 5-FU with BP-C3 prior to and following administration of the chemotherapeutic agent (preventative/therapeutic schedule), mild anaemia developed by day 7. Administration of BP-C3 without 5-FU did not affect blood cell differentiation in the mice. Thus, BP-C3, depending on the administration schedule, had different effects on the haematological parameters of haematopoietic organs and peripheral blood in mice exposed to 5-FU. BP-C3 promoted intestinal crypt survival when administered on the preventative/therapeutic and therapeutic schedules, suggesting that the formulation protects the epithelium of the small intestine against damage by 5-FU.

Entities:  

Keywords:  5-fluorouracil; benzenepolycarboxylic acids; blood count; chemotherapy; intestinal crypt survival; polyphenol composition BP-C3; toxicity

Year:  2018        PMID: 29599844      PMCID: PMC5867459          DOI: 10.3892/etm.2018.5782

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  31 in total

Review 1.  Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?

Authors:  Brian D Lawenda; Kara M Kelly; Elena J Ladas; Stephen M Sagar; Andrew Vickers; Jeffrey B Blumberg
Journal:  J Natl Cancer Inst       Date:  2008-05-27       Impact factor: 13.506

Review 2.  The detoxification enzyme systems.

Authors:  D J Liska
Journal:  Altern Med Rev       Date:  1998-06

3.  Balancing the efficacy and toxicity of chemotherapy in colorectal cancer.

Authors:  Michael S Braun; Matthew T Seymour
Journal:  Ther Adv Med Oncol       Date:  2011-01       Impact factor: 8.168

4.  Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate.

Authors:  D V Santi; C S McHenry; H Sommer
Journal:  Biochemistry       Date:  1974-01-29       Impact factor: 3.162

Review 5.  Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.

Authors:  M A Poon; M J O'Connell; C G Moertel; H S Wieand; S A Cullinan; L K Everson; J E Krook; J A Mailliard; J A Laurie; L K Tschetter
Journal:  J Clin Oncol       Date:  1989-10       Impact factor: 44.544

Review 6.  Antioxidants in cancer therapy; their actions and interactions with oncologic therapies.

Authors:  D W Lamson; M S Brignall
Journal:  Altern Med Rev       Date:  1999-10

Review 7.  Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.

Authors:  Reason Wilken; Mysore S Veena; Marilene B Wang; Eri S Srivatsan
Journal:  Mol Cancer       Date:  2011-02-07       Impact factor: 27.401

Review 8.  Antioxidant Intake and Antitumor Therapy: Toward Nutritional Recommendations for Optimal Results.

Authors:  Nuria Mut-Salud; Pablo Juan Álvarez; Jose Manuel Garrido; Esther Carrasco; Antonia Aránega; Fernando Rodríguez-Serrano
Journal:  Oxid Med Cell Longev       Date:  2015-11-22       Impact factor: 6.543

Review 9.  Polyphenols as Modulator of Oxidative Stress in Cancer Disease: New Therapeutic Strategies.

Authors:  Anna Maria Mileo; Stefania Miccadei
Journal:  Oxid Med Cell Longev       Date:  2015-11-16       Impact factor: 6.543

10.  In Vivo Chemoprotective Activity of Bovine Dialyzable Leukocyte Extract in Mouse Bone Marrow Cells against Damage Induced by 5-Fluorouracil.

Authors:  Erika Evangelina Coronado-Cerda; Moisés Armides Franco-Molina; Edgar Mendoza-Gamboa; Heriberto Prado-García; Lydia Guadalupe Rivera-Morales; Pablo Zapata-Benavides; María Del Carmen Rodríguez-Salazar; Diana Caballero-Hernandez; Reyes Silvestre Tamez-Guerra; Cristina Rodríguez-Padilla
Journal:  J Immunol Res       Date:  2016-04-17       Impact factor: 4.818

View more
  4 in total

1.  The Effect of Polyphenolic Composition BP-C3 on the Efficacy and Hematological Toxicity of Cyclophosphamide in the Chemotherapy of Mice Bearing Soft Tissue Sarcomas Induced by Benzo[a]pyrene.

Authors:  Andrey V Panchenko; Elena I Fedoros; Sergey E Pigarev; Mikhail A Maydin; Ekaterina A Gubareva; Galina S Kireeva; Margarita L Tyndyk; Anastasia I Kuznetsova; Tatyana L Nekhaeva; Anna B Danilova; Irina A Baldueva; Vladimir N Anisimov
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

2.  Novel water-soluble lignin derivative BP-Cx-1: identification of components and screening of potential targets in silico and in vitro.

Authors:  Elena I Fedoros; Alexey A Orlov; Alexander Zherebker; Ekaterina A Gubareva; Mikhail A Maydin; Andrey I Konstantinov; Konstantin A Krasnov; Ruben N Karapetian; Ekaterina I Izotova; Sergey E Pigarev; Andrey V Panchenko; Margarita L Tyndyk; Dmitry I Osolodkin; Evgeny N Nikolaev; Irina V Perminova; Vladimir N Anisimov
Journal:  Oncotarget       Date:  2018-04-06

3.  The small organic molecule C19 binds and strengthens the KRAS4b-PDEδ complex and inhibits growth of colorectal cancer cells in vitro and in vivo.

Authors:  Pedro Cruz-Nova; Michael Schnoor; José Correa-Basurto; Martiniano Bello; Paola Briseño-Diaz; Arturo Rojo-Domínguez; Carlos M Ortiz-Mendoza; Jorge Guerrero-Aguirre; Francisco J García-Vázquez; Rosaura Hernández-Rivas; María Del Rocío Thompson-Bonilla; Miguel Vargas
Journal:  BMC Cancer       Date:  2018-11-01       Impact factor: 4.430

4.  A Use of Tritium-Labeled Peat Fulvic Acids and Polyphenolic Derivatives for Designing Pharmacokinetic Experiments on Mice.

Authors:  Gennady A Badun; Maria G Chernysheva; Yury V Zhernov; Alina S Poroshina; Valery V Smirnov; Sergey E Pigarev; Tatiana A Mikhnevich; Dmitry S Volkov; Irina V Perminova; Elena I Fedoros
Journal:  Biomedicines       Date:  2021-11-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.